Antoine Italiano, MD, PhD

Head
Department of Medicine, Institut Bergonié
Bordeaux, Aquitaine, France

Presentation(s):

• Paper 13 - CONGRATS: A RANDOMIZED PHASE II STUDY OF NIVOLUMAB ± RELATLIMAB IN PATIENTS WITH TLS-POSITIVE ADVANCED SOFT-TISSUE SARCOMAS

  Thursday, November 13, 2025
  1:30 PM - 3:00 PM EST

  Disclosure information not submitted.

• Paper 45 - LONG-TERM EFFICACY AND SAFETY OF VIMSELTINIB IN PATIENTS (PTS) WITH TENOSYNOVIAL GIANT CELL TUMOR (TGCT): RESULTS FROM THE MOTION PHASE 3 TRIAL

  Friday, November 14, 2025
  2:30 PM - 3:30 PM EST

  Disclosure information not submitted.